Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2004 Jan-Feb;18(1):29-33.

Local and systemic administration of corticosteroids in the treatment of olfactory loss

Affiliations
  • PMID: 15035568
Clinical Trial

Local and systemic administration of corticosteroids in the treatment of olfactory loss

Stefan Heilmann et al. Am J Rhinol. 2004 Jan-Feb.

Abstract

Background: The aim of this study was to evaluate the benefit of patients with olfactory dysfunction from local (group A) or systemic (group B) administration of corticosteroids.

Methods: This unblinded study was conducted at a smell and taste outpatient clinic of an institutional referral center. Patients with olfactory loss after infections of the upper respiratory tract, patients with apparent sinonasal disease, and patients suffering from "idiopathic" smell loss were included. Effects of mometasone nasal spray, administered for 1-3 months, were studied in 37 patients. In addition, effects of oral prednisolone were analyzed in 55 patients who received decreasing doses over 21 days, starting with a dose of 40 mg. Olfactory function before and after treatment was measured.

Results: Although odor identification scores tended to increase (p = 0.05), mometasone nasal spray did not significantly improve olfactory function, when looking at the entire group of patients or when analyzing the three diagnostic categories separately. In contrast, after systemic administration of corticosteroids, improvement of olfactory function was seen over all diagnostic categories (p < 0.001). Interestingly, olfactory function also improved in patients diagnosed with olfactory loss after upper respiratory tract infection (p = 0.05) and in patients initially diagnosed with "idiopathic," olfactory dysfunction (p = 0.008).

Conclusion: In many patients, local application of corticosteroids appears to have little or no positive effect on olfactory dysfunction, especially when considering long-term changes. Duration of disease, the patient's age/sex, or the presence of parosmia does not appear to predict the response to therapy with corticosteroids.

PubMed Disclaimer

Similar articles

Cited by

  • Delivery of Topical Drugs to the Olfactory Cleft.
    Espehana A, Lee L, Garden EM, Klyvyte G, Gokani S, Jegatheeswaran L, Wong JJ, Philpott C. Espehana A, et al. J Clin Med. 2023 Nov 29;12(23):7387. doi: 10.3390/jcm12237387. J Clin Med. 2023. PMID: 38068438 Free PMC article. Review.
  • The Effect of Corticosteroids on Post-Covid-19 Smell Loss: A Meta-Analysis.
    Kabiri M, Emadzadeh M. Kabiri M, et al. Iran J Otorhinolaryngol. 2023 Sep;35(130):235-246. doi: 10.22038/IJORL.2023.72451.3456. Iran J Otorhinolaryngol. 2023. PMID: 38090618 Free PMC article.
  • Clinical effects of intranasal corticosteroids on nasal symptoms in subjects with chronic rhinitis during COVID-19.
    Tuzer C, Karadag P, Yegit O, Eyice D, Oztop N, Can A, Demir S, Coskun R, Erdogdu Unal D, Olgac M, Buyukozturk S, Colakoglu B, Gelincik A. Tuzer C, et al. Allergy Asthma Proc. 2022 Mar 1;43(2):106-115. doi: 10.2500/aap.2022.43.210116. Allergy Asthma Proc. 2022. PMID: 35317887 Free PMC article.
  • International consensus statement on allergy and rhinology: Olfaction.
    Patel ZM, Holbrook EH, Turner JH, Adappa ND, Albers MW, Altundag A, Appenzeller S, Costanzo RM, Croy I, Davis GE, Dehgani-Mobaraki P, Doty RL, Duffy VB, Goldstein BJ, Gudis DA, Haehner A, Higgins TS, Hopkins C, Huart C, Hummel T, Jitaroon K, Kern RC, Khanwalkar AR, Kobayashi M, Kondo K, Lane AP, Lechner M, Leopold DA, Levy JM, Marmura MJ, Mclelland L, Miwa T, Moberg PJ, Mueller CA, Nigwekar SU, O'Brien EK, Paunescu TG, Pellegrino R, Philpott C, Pinto JM, Reiter ER, Roalf DR, Rowan NR, Schlosser RJ, Schwob J, Seiden AM, Smith TL, Soler ZM, Sowerby L, Tan BK, Thamboo A, Wrobel B, Yan CH. Patel ZM, et al. Int Forum Allergy Rhinol. 2022 Apr;12(4):327-680. doi: 10.1002/alr.22929. Int Forum Allergy Rhinol. 2022. PMID: 35373533 Free PMC article. Review.
  • Effects of Tokishakuyakusan on Regeneration of Murine Olfactory Neurons In Vivo and In Vitro.
    Noda T, Shiga H, Yamada K, Harita M, Nakamura Y, Ishikura T, Kumai M, Kawakami Z, Kaneko A, Hatta T, Sakata-Haga H, Shimada H, Miwa T. Noda T, et al. Chem Senses. 2019 May 29;44(5):327-338. doi: 10.1093/chemse/bjz023. Chem Senses. 2019. PMID: 30989168 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources